Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Experimental Cell Research
|
November 1, 1994
Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells
S Kataoka, M Naito, A Tomida, et al.
Biochemical and Biophysical Research Communications
|
May 18, 1999
Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells
Y Ogiso, A Tomida, H D Kim, et al.
Oncogene
|
December 19, 1996
Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells
A Tomida, H Suzuki, H D Kim, et al.
Journal of Cellular Physiology
|
June 11, 1999
Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells
H D Kim, A Tomida, Y Ogiso, et al.
The Journal of Antibiotics
|
February 1, 1990
Resorthiomycin, a novel antitumor antibiotic. III. Potentiation of antitumor drugs and its mechanism of action
M Tahara, A Tomida, T Nishimura, et al.
Japanese Journal of Cancer Research : Gann
|
November 21, 2001
Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D
K Kurosawa, K Takahashi, E Tsuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines
M Yamada, A Tomida, H Yoshikawa, et al.
Cancer Research
|
May 16, 2000
Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs
Y Ogiso, A Tomida, S Lei, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 26, 1999
Modulation of multidrug resistance in tumor cells by taxinine derivatives
H Hosoyama, H Shigemori, A Tomida, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
April 1, 1977
[Experimental and clinical studies of C peptides radioimmunoassay]
T Itazu, O Shibata, A Tomida, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Experimental Cell Research
|
November 1, 1994
Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells
S Kataoka, M Naito, A Tomida, et al.
Biochemical and Biophysical Research Communications
|
May 18, 1999
Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells
Y Ogiso, A Tomida, H D Kim, et al.
Oncogene
|
December 19, 1996
Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells
A Tomida, H Suzuki, H D Kim, et al.
Journal of Cellular Physiology
|
June 11, 1999
Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells
H D Kim, A Tomida, Y Ogiso, et al.
The Journal of Antibiotics
|
February 1, 1990
Resorthiomycin, a novel antitumor antibiotic. III. Potentiation of antitumor drugs and its mechanism of action
M Tahara, A Tomida, T Nishimura, et al.
Japanese Journal of Cancer Research : Gann
|
November 21, 2001
Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D
K Kurosawa, K Takahashi, E Tsuda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines
M Yamada, A Tomida, H Yoshikawa, et al.
Cancer Research
|
May 16, 2000
Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs
Y Ogiso, A Tomida, S Lei, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 26, 1999
Modulation of multidrug resistance in tumor cells by taxinine derivatives
H Hosoyama, H Shigemori, A Tomida, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
April 1, 1977
[Experimental and clinical studies of C peptides radioimmunoassay]
T Itazu, O Shibata, A Tomida, et al.
Page
of 4